首页> 外国专利> COMPOSITE OF HYDROPHYLIC POLYMERIC OLIGOPEPTIDE HYDROPHYLIC AND MEDICINES, MEDICAL COMPOSITION THAT INCLUDES THE MENTIONED COMPOUND AND THE USE OF THE COMPOSITE MENTIONED IN MEDICINES.

COMPOSITE OF HYDROPHYLIC POLYMERIC OLIGOPEPTIDE HYDROPHYLIC AND MEDICINES, MEDICAL COMPOSITION THAT INCLUDES THE MENTIONED COMPOUND AND THE USE OF THE COMPOSITE MENTIONED IN MEDICINES.

机译:药物和药物的复合物,药物组合物,包括所提及的化合物以及在药物中所提及的组合物的用途。

摘要

A conjugate of hydrophilic polymeric polycarboxylic oligopeptide and drug molecule of the following formula: ** (See formula) ** where: P is a water-soluble polymer selected from the group consisting of polyethylene glycol, polypropylene glycol, polyvinyl alcohol, polyacrylmorpholine and copolymers thereof; m is an integer from 2-12; j is an integer from 1-6; Ri is a group selected from the group consisting of H, C1-12 alkyl, substituted aryl, aralkyl, heteroalkylene and substituted alkyl; X is a connection group selected from (CH2) i, (CH2) and OCO, (CH2) i NHCO and (CH2) iCO, where i is an integer from 0-10; Z is a connection group selected from O and NH; and TA is any one selected from the group consisting of cinobufagina, glycyrrhizinic acid, paclitaxel, camptothecin, hydroxycamptothecin and etoposide.
机译:亲水性高分子聚羧酸寡肽与下式的药物分子的共轭物:**(参见式)**其中:P是选自聚乙二醇,聚丙二醇,聚乙烯醇,聚丙烯吗啉和共聚物的水溶性聚合物其中m是2-12的整数; j是1-6的整数; Ri是选自H,C1-12烷基,取代的芳基,芳烷基,杂亚烷基和取代的烷基的基团; X为选自(CH 2)i,(CH 2)和OCO,(CH 2)i NHCO和(CH 2)iCO的连接基团,其中i为0-10的整数; Z是选自O和NH的连接基团; TA选自cinobufagina,甘草次酸,紫杉醇,喜树碱,羟基喜树碱和依托泊苷。

著录项

  • 公开/公告号ES2340374T3

    专利类型

  • 公开/公告日2010-06-02

    原文格式PDF

  • 申请/专利权人 BEIJING JIANKAI TECHNOLOGY CO. LTD.;

    申请/专利号ES20030711787T

  • 发明设计人 JI SHISHAN;ZHU DEQUAN;

    申请日2003-03-05

  • 分类号A61K47/48;A61K9/02;A61K9/08;A61K9/10;A61K9/12;A61K9/14;A61K9/20;A61K9/48;C07K5/06;C07K5/072;C08G81;

  • 国家 ES

  • 入库时间 2022-08-21 18:43:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号